Satsuma Pharmaceuticals, Inc.

CITADEL ADVISORS LLC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

5,397

Value ($000)

4

Weight

0.0%

2019 Q4 - 2023 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	4	0.0%	5,397	3/31/2023
2022 Q4	2/14/2023	9	0.0%	9,912	12/31/2022
2022 Q2	8/15/2022	624	0.0%	150,954	6/30/2022
2022 Q1	5/16/2022	706	0.0%	185,610	3/31/2022
2021 Q4	2/14/2022	4,840	0.0%	1,075,620	12/31/2021
2021 Q3	11/15/2021	4,999	0.0%	1,072,614	9/30/2021
2021 Q2	8/16/2021	8,625	0.0%	1,226,832	6/30/2021
2021 Q1	5/21/2021	7,314	0.0%	1,237,498	3/31/2021
2020 Q4	2/16/2021	1,682	0.0%	364,785	12/31/2020
2020 Q3	11/16/2020	1,506	0.0%	387,313	9/30/2020
2020 Q2	8/14/2020	29,569	0.0%	1,028,120	6/30/2020
2020 Q1	5/15/2020	21,959	0.0%	1,020,417	3/31/2020
2019 Q4	2/14/2020	20,024	0.0%	1,017,482	12/31/2019